« Back
Home /
Vadimezan (DMXAA)

Vadimezan (DMXAA)

Item no.	S1537-10mM
Manufacturer	Selleckchem
CASRN	117570-53-3
Amount	10 mM/1 mL
Quantity options	100 mg 1 g 10 g 10 mM/1 mL 10 mg 25 mg 5 mg 5 g
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	CC1=C(C2=C(C=C1)C(=O)C3=CC=CC(=C3O2)CC(=O)O)C
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	ASA404,NSC 640488
Similar products	117570-53-3
Available
Storage Conditions	2 years -80 in solvent
Information	Vadimezan (DMXAA) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. DMXAA (Vadimezan) is also a STING agonist with potential antineoplastic activity. DMXAA (Vadimezan) potently induces IFN-β but relatively low TNF-α expression in vitro. DMXAA (Vadimezan) has antiviral activity. Phase 3.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S1537-10mM-datasheet.pdf

S1537-10mM-safety-datasheet.pdf